547. TRANSCRANIAL MAGNETIC STIMULATION IN LESS COMMON INDICATIONS - FOCUSED ON SCHIZOPHRENIA AND BORDERLINE PERSONALITY DISORDER

Abstract Background Repetitive transcranial magnetic stimulation (rTMS) is an established therapeutic method for the treatment of several neuropsychiatric disorders. This fully applies to the treatment of major depressive disorder, including patients with treatment-resistant depression. Aims & Objectives The efficacy of this non-invasive neurostimulation method in other indications including schizophrenia is less clear. In the case of negative symptoms, its efficacy was rated as B (probably effective) in the international guidelines (Lefaucheur et al., 2014). When these guidelines were updated six years later, the efficacy rating was downgraded to C (potentially effective) (Lefaucheur et al., 2020). This change was based on a large German study that did not demonstrate the efficacy of rTMS on negative symptoms (Wobrock et al., 2015). Method To verify these results, we therefore conducted another multicenter Czech-German study assessing high-frequency rTMS of the left dorsolateral prefrontal cortex and comparing it with intermittent theta-burst stimulation (iTBS) and sham stimulation. Patients underwent a total of twenty sessions in four consecutive weeks. Results A total of 54 patients were included in the study. At the end, we found a significant reduction in the severity of negative symptoms in all three groups, the difference between the groups was not significant. Discussion & Conclusions Even less is known about the potential use of rTMS in borderline personality disorder than in schizophrenia, although some pilot results are promising (Benster et al., 2023). In our ongoing study, we are assessing the efficacy of high-frequency rTMS targeted to the right dorsolateral prefrontal cortex with or without Dialectical behavior therapy (DBT) compared to sham stimulation (with or without DBT). Pilot results of rTMS (active and sham) without DBT will be presented for the first time at the conference.

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-08-01
DOI
https://doi.org/10.1093/ijnp/pyaf052.365
Primary Topic
Transcranial Magnetic Stimulation Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

547. TRANSCRANIAL MAGNETIC STIMULATION IN LESS COMMON INDICATIONS - FOCUSED ON SCHIZOPHRENIA AND BORDERLINE PERSONALITY DISORDER

Libor Ustohal
The International Journal of Neuropsychopharmacology
Transcranial Magnetic Stimulation Studies
article

547. TRANSCRANIAL MAGNETIC STIMULATION IN LESS COMMON INDICATIONS - FOCUSED ON SCHIZOPHRENIA AND BORDERLINE PERSONALITY DISORDER

Libor Ustohal
article en

Abstract

Abstract Background Repetitive transcranial magnetic stimulation (rTMS) is an established therapeutic method for the treatment of several neuropsychiatric disorders. This fully applies to the treatment of major depressive disorder, including patients with treatment-resistant depression. Aims & Objectives The efficacy of this non-invasive neurostimulation method in other indications including schizophrenia is less clear. In the case of negative symptoms, its efficacy was rated as B (probably effective) in the international guidelines (Lefaucheur et al., 2014). When these guidelines were updated six years later, the efficacy rating was downgraded to C (potentially effective) (Lefaucheur et al., 2020). This change was based on a large German study that did not demonstrate the efficacy of rTMS on negative symptoms (Wobrock et al., 2015). Method To verify these results, we therefore conducted another multicenter Czech-German study assessing high-frequency rTMS of the left dorsolateral prefrontal cortex and comparing it with intermittent theta-burst stimulation (iTBS) and sham stimulation. Patients underwent a total of twenty sessions in four consecutive weeks. Results A total of 54 patients were included in the study. At the end, we found a significant reduction in the severity of negative symptoms in all three groups, the difference between the groups was not significant. Discussion & Conclusions Even less is known about the potential use of rTMS in borderline personality disorder than in schizophrenia, although some pilot results are promising (Benster et al., 2023). In our ongoing study, we are assessing the efficacy of high-frequency rTMS targeted to the right dorsolateral prefrontal cortex with or without Dialectical behavior therapy (DBT) compared to sham stimulation (with or without DBT). Pilot results of rTMS (active and sham) without DBT will be presented for the first time at the conference.

The International Journal of NeuropsychopharmacologyVol. 28(Supplement_2)
Masaryk University (CZ)
Openalex Percentile: Top 73%
Transcranial Magnetic Stimulation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

547. TRANSCRANIAL MAGNETIC STIMULATION IN LESS COMMON INDICATIONS - FOCUSED ON SCHIZOPHRENIA AND BORDERLINE PERSONALITY DISORDER — Libor Ustohal · The International Journal of Neuropsychopharmacology (2025) | TGRS Research Map | TGRS